These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7017056)

  • 1. Health risks of oestrogen therapy.
    MacRae KD
    J Endocrinol; 1981; 89 Suppl():145P-148P. PubMed ID: 7017056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives and MI: how strong is the link?
    Jick H
    J Cardiovasc Med; 1982 May; 7(5):481, 484-5. PubMed ID: 12311565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
    Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pill: an evaluation of recent studies.
    Rosenfield A
    Johns Hopkins Med J; 1982 May; 150(5):177-80. PubMed ID: 7043036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The estrogen component of OCs: cardiovascular benefits and risks.
    Burkman RT
    Int J Fertil Womens Med; 1997; Suppl 1():145-57. PubMed ID: 9168374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and venous thromboembolism: consensus conference statement.
    Dialogues in Contraception Consensus Conference (1995: Chicago)
    Dialogues Contracept; 1996; ():1-8. PubMed ID: 12320455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
    Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancers of the uterus and ovary and the contraceptive pill].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):339-43. PubMed ID: 12280204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
    Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
    Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pill and cancer--IPPF response.
    IPPF Med Bull; 1983 Dec; 17(6):1-2. PubMed ID: 12279693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens and endometrial cancer.
    Horwitz RI; Feinstein AR
    N Engl J Med; 1979 Jun; 300(23):1333-4. PubMed ID: 440341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.